Reuters logo
BRIEF-Mustang Bio announces $12.8 mln grant to fund Phase 1 trial of CAR T therapy MB-101 in malignant glioma
October 11, 2017 / 11:48 AM / 2 months ago

BRIEF-Mustang Bio announces $12.8 mln grant to fund Phase 1 trial of CAR T therapy MB-101 in malignant glioma

Oct 11 (Reuters) - Fortress Biotech Inc:

* Mustang Bio announces $12.8 million grant to fund Phase 1 trial of CAR T therapy MB-101 in malignant glioma Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below